Abstract | UNLABELLED: AIM of this study was to localize the sentinel lymph node by lymphoscintigraphy using technetium-99m colloidal rhenium sulphide ( Nanocis), a new commercially available radiopharmaceutical. Due to the manufacturers' instructions it is licensed for lymphoscintigraphy. PATIENTS AND METHODS: 35 consecutive patients with histologically proved malignant melanoma, but without clinical evidence of metastases, were preoperatively examined by injecting 20-40 MBq Nanocis with (mean particle size: 100 nm; range: 50-200 nm) intradermally around the lesion. Additionally blue dye was injected intraoperatively. A hand-held gamma probe guided sentinel node biopsy. RESULTS: During surgery, the preoperatively scintigraphically detected sentinel lymph nodes were identified in 34/35 (97%) patients. The number of sentinel nodes per patient ranged from one to four (mean: n = 1.8). Histologically, metastatic involvement of the sentinel lymph node was found in 12/35 (34%) patients; the sentinel lymph node positive-rate (14/63 SLN) was 22%. Thus, it is comparable to the findings of SLN-mapping using other technetium-99m-labeled nanocolloides. CONCLUSION: (99m)Tc-bound colloidal rhenium sulphide is also suitable for sentinel node mapping.
|
Authors | M Weiss, R A Schmid, C Kunte, B Konz, K Hahn |
Journal | Nuklearmedizin. Nuclear medicine
(Nuklearmedizin)
Vol. 43
Issue 1
Pg. 10-5
(Feb 2004)
ISSN: 0029-5566 [Print] Germany |
Vernacular Title | Erste Erfahrungen mit einem neuen Radiopharmakon für die Wächterlymphknoten - Detektion beim malignen Melanom: (99m)Tc markiertes kolloidales Rheniumsulfid. |
PMID | 14978535
(Publication Type: Journal Article)
|
Chemical References |
- Radiopharmaceuticals
- Technetium Compounds
- technetium Tc 99m rhenium colloid
- Rhenium
|
Topics |
- Adult
- Aged
- Female
- Humans
- Melanoma
(diagnostic imaging, pathology)
- Middle Aged
- Radionuclide Imaging
- Radiopharmaceuticals
- Reproducibility of Results
- Rhenium
- Sentinel Lymph Node Biopsy
(methods)
- Technetium Compounds
|